Patent intelligence · US
US 10351628
Antibody fragments, compositions and uses thereof
Antibody fragments, compositions and uses thereof
Patent details — US 10351628
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 16, 2019
- Expiration
- Jul 11, 2039
- Applicant
- METIS PRECISION MEDICINE SB S.R.L.
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06
Quick answer
US 10351628 (Antibody fragments, compositions and uses thereof) is held by METIS PRECISION MEDICINE SB S.R.L.. Status: granted. Granted Jul 16, 2019. Expires Jul 11, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- METIS PRECISION MEDICINE SB S.R.L.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61K48/0016, A61P
More from METIS PRECISION MEDICINE SB S.R.L.
Related pharmaceutical patents in our USPTO index.
-
US 12419920
Bifidobacterium longum NCIMB 41676
granted -
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12351839
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 12344676
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 12336835
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12232492
Disinfection of bacteriophages products using supercritical carbon dioxide
granted -
US 12233135
Therapeutic constructs for treating cancer
granted -
US 12180463
Lactobacillus reuteri
granted
Frequently asked questions
What is US patent 10351628?
US 10351628 (Antibody fragments, compositions and uses thereof) is held by METIS PRECISION MEDICINE SB S.R.L.. Status: granted. Granted Jul 16, 2019. Expires Jul 11, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10351628?
METIS PRECISION MEDICINE SB S.R.L. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 158 pharmaceutical patents for this assignee.
When does US 10351628 expire?
Our index shows an expiration date of Jul 11, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.